YUBO INTERNATIONAL BIOTECH LIMITED

(YBGJ)
Delayed OTC Markets  -  05/20 11:59:28 am EDT
0.0702 USD   -49.86%
05/16YUBO INTERNATIONAL BIOTECH LTD Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
05/16Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/15YUBO INTERNATIONAL BIOTECH LTD Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021

11/15/2021 | 04:37pm EDT

Yubo International Biotech Limited reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 0.098303 million compared to USD 0.194459 million a year ago. Net loss was USD 0.336584 million compared to USD 0.304712 million a year ago. For the nine months, sales was USD 0.912103 million compared to USD 0.471148 million a year ago. Net loss was USD 1.15 million compared to USD 0.430301 million a year ago. Basic loss per share from continuing operations was USD 0.01.


© S&P Capital IQ 2021
All news about YUBO INTERNATIONAL BIOTECH LIMITED
05/16YUBO INTERNATIONAL BIOTECH LTD Management's Discussion and Analysis of Financial Condi..
AQ
05/16Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended..
CI
04/15YUBO INTERNATIONAL BIOTECH LTD Management's Discussion and Analysis of Financial Condi..
AQ
04/15Yubo International Biotech Limited Reports Earnings Results for the Full Year Ended Dec..
CI
2021YUBO INTERNATIONAL BIOTECH LTD Management's Discussion and Analysis of Financial Condi..
AQ
2021Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and N..
CI
2021YUBO INTERNATIONAL BIOTECH : Management's Discussion and Analysis of Financial Condition a..
AQ
2021Yubo International Biotech Limited Reports Earnings Results for the Second Quarter Ende..
CI
2021YUBO INTERNATIONAL BIOTECH : Management's Discussion and Analysis of Financial Condition a..
AQ
2021Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended..
CI
More news
Financials (USD)
Sales
Net income
Net Debt
P/E ratio
Yield
Capitalization 8,30 M 8,30 M -
EV / Sales -1
EV / Sales 0
Nbr of Employees 20
Free-Float 5,25%
Chart YUBO INTERNATIONAL BIOTECH LIMITED
Duration : Period :
Yubo International Biotech Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Jun Wang President
Lina Liu Chief Financial Officer
Wang Yang General Manager
Zhi Hui Bai Director
Sector and Competitors
1st jan.Capi. (M$)
YUBO INTERNATIONAL BIOTECH LIMITED-83.16%8
INVESTOR AB (PUBL)-17.69%57 656
CK HUTCHISON HOLDINGS LIMITED12.13%27 550
GROUPE BRUXELLES LAMBERT SA-12.90%13 317
HAL TRUST-8.23%12 397
AB INDUSTRIVÄRDEN (PUBL)-10.99%11 227